TP53 and cancer: Collectively, our results reveal a novel mechanism by which ALKBH5 shRNA-loaded BMSC-Exos suppresses TNBC cell stemness and retards tumor growth and metastasis through the UBE2C/p53 axis, which renders varieties of potential molecular targets in cancer therapy of TNBC.